Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in normal clinical practice conditions in the Czech Republic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Menopause Hormone Replacement Therapy, Post-Menopausal

Sex eligibility

Female

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Prague, Czechia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Post-menopausal

Treatment and study plan

Marketed low dose hormone replacement therapy

Drug

A low dose of marketed HRT products prescribed at the discretion of the treating physician

Primary outcomes

Breast tenderness

Secondary outcomes

Patient treatment satisfaction after switch to low dose HRT

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Official study title

Impact of Professional Societies Recommendations on Practical Use of Hormone Replacement Therapy - Project "WOMAN 2005"

Important dates

Study start: 2005
Primary completion: 2006
Study completion: 2006
First posted: Dec 7, 2011
Registry last updated: Oct 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting